Determinants of follow-up care utilization among young breast cancer survivors: Results from a nationwide study
Tuesday, November 5, 2013
: 11:00 a.m. - 11:15 a.m.
The number of breast cancer survivors is increasing. With the longer survival period, comprehensive follow-up care is necessary. The aim of this study is to explore the determinants of survivorship care among breast cancer survivors, including the socioeconomic and healthcare-related factors.We built a retrospective cohort study starting 366 days post-diagnosis. Stage I-III breast cancer women younger than 50 year-old, diagnosed from 2004 to 2007 were included (n=9847). Using the national health insurance database, cancer registry data and death registry data, we examined the survivorship care utilization, including surveillance (i.e. breast ultrasound and mammography) and preventive care (i.e. cholesterol screening, cardiac ultrasound, abdominal ultrasound), in the survivorship year 1 (days 366 to 730 postdiagnosis). We evaluated trends over time using the CochranArmitage trend test. Multivariable logistic regression models were used to identify determinants.A significant increasing trend (p< .0001) in follow-up care was observed between 2004 and 2007. The majority of survivors (81%) were followed by both oncology specialists and primary care providers (PCPs). Breast cancer survivors, who were younger, diagnosed at earlier stages, more comorbidities, higher socioeconomic status, living in urban areas, treated in medical centers and public hospitals, and who were followed by both specialists and PCPs, may have better chance to receive appropriate follow-up care.
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Analyze the follow-up care utilization, including surveillance and preventive care
Identify of the determinants of follow-up care among young breast cancer survivors
Keyword(s): Cancer, Preventive Medicine
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am qualified to be an abstract Author on the content I am responsible for because: I built conceptual model, analyzed data, and wrote the abstract and manuscript with the co-authors.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.